Paolo Tarantino
Paolo Tarantino
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
2Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA USA
3Harvard Medical School, Boston, MA USA
4Department of Oncology and Hematology-Oncology, University of Milano, Milano, Italy
1,2,3,4,✉,#,
Hersh Gupta
Hersh Gupta
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
5Broad Institute of Harvard and MIT, Cambridge, MA USA
1,5,#,
Melissa E Hughes
Melissa E Hughes
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
1,
Janet Files
Janet Files
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
1,
Sarah Strauss
Sarah Strauss
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
1,
Gregory Kirkner
Gregory Kirkner
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
1,
Anne-Marie Feeney
Anne-Marie Feeney
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
1,
Yvonne Li
Yvonne Li
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
1,
Ana C Garrido-Castro
Ana C Garrido-Castro
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
2Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA USA
3Harvard Medical School, Boston, MA USA
1,2,3,
Romualdo Barroso-Sousa
Romualdo Barroso-Sousa
6Dasa Institute for Education and Research (IEPD), Brasilia, Brazil
7Dasa Oncology/Hospital Brasilia, Brasilia, Brazil
6,7,
Brittany L Bychkovsky
Brittany L Bychkovsky
2Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA USA
3Harvard Medical School, Boston, MA USA
8Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA USA
2,3,8,
Simona DiLascio
Simona DiLascio
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
1,
Lynette Sholl
Lynette Sholl
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
1,
Laura MacConaill
Laura MacConaill
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
1,
Neal Lindeman
Neal Lindeman
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
12Present Address: Department of Pathology, Weill Cornell Medicine, New York, NY USA
1,12,
Bruce E Johnson
Bruce E Johnson
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
1,
Matthew Meyerson
Matthew Meyerson
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
3Harvard Medical School, Boston, MA USA
5Broad Institute of Harvard and MIT, Cambridge, MA USA
1,3,5,
Rinath Jeselsohn
Rinath Jeselsohn
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
2Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA USA
3Harvard Medical School, Boston, MA USA
1,2,3,
Xintao Qiu
Xintao Qiu
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
1,
Rong Li
Rong Li
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
1,
Henry Long
Henry Long
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
1,
Eric P Winer
Eric P Winer
9Yale Cancer Center, Yale School of Medicine, Smilow Cancer Hospital, New Haven, CT USA
9,
Deborah Dillon
Deborah Dillon
3Harvard Medical School, Boston, MA USA
10Department of Pathology, Brigham and Women’s Hospital, Boston, MA USA
3,10,
Giuseppe Curigliano
Giuseppe Curigliano
11Division of Early Drug Development, European Institute of Oncology IRCCS, Milano, Italy
11,
Andrew D Cherniack
Andrew D Cherniack
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
3Harvard Medical School, Boston, MA USA
5Broad Institute of Harvard and MIT, Cambridge, MA USA
1,3,5,
Sara M Tolaney
Sara M Tolaney
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
2Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA USA
3Harvard Medical School, Boston, MA USA
1,2,3,
Nancy U Lin
Nancy U Lin
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
2Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA USA
3Harvard Medical School, Boston, MA USA
1,2,3
1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
2Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA USA
3Harvard Medical School, Boston, MA USA
4Department of Oncology and Hematology-Oncology, University of Milano, Milano, Italy
5Broad Institute of Harvard and MIT, Cambridge, MA USA
6Dasa Institute for Education and Research (IEPD), Brasilia, Brazil
7Dasa Oncology/Hospital Brasilia, Brasilia, Brazil
8Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA USA
9Yale Cancer Center, Yale School of Medicine, Smilow Cancer Hospital, New Haven, CT USA
10Department of Pathology, Brigham and Women’s Hospital, Boston, MA USA
11Division of Early Drug Development, European Institute of Oncology IRCCS, Milano, Italy
12Present Address: Department of Pathology, Weill Cornell Medicine, New York, NY USA
Subject terms: Breast cancer, Breast cancer
© The Author(s) 2023
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
